Two decades of inadequate funding have rendered the Food and Drug Administration's (FDA’s) scientific capacity insufficient to meet the growing demands of ensuring the public's health and safety,
according to a report issued in December by an advisory group to the agency.
Advances in science, greater complexity in the products it regulates,
and globalization of FDA-regulated industries are among the trends placing unprecedented demands on the FDA, yet resources for the agency's science infrastructure and staff have been stagnant, according to the 300-page report (http://www.fda.gov/ohrms/dockets/ac/07/briefing/2007-4329b_02_01_FDA%20Report%20on%20Science%20and%20Technology.pdf).
Kuehn BM. FDA’s Science Infrastructure Failing. JAMA. 2008;299(2):157–158. doi:10.1001/jama.2007.53
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: